Natural cycle as first approach in aged patients with elevated follicle-stimulating hormone undergoing intracytoplasmic sperm injection: A pilot study

References

• Steptoe P G, Edwards R G. Birth after reimplantation of a human embryo. Lancet 1978; 2: 366
   PubMed Web of Science ®Google Scholar
• Hughes E G, Fedorkow D M, Daya S, Sagle M A, Van de Koppel P, Collins J A. The routine use of gonadotropin-releasing hormone agonists prior to in vitro fertilization and gamete intrafallopian transfer: a meta-analysis of randomized controlled trials. Fertil Steril 1992; 58: 888–896
   PubMed Web of Science ®Google Scholar
• Keay S D, Liversedge N H, Jenkins J M. Assisted conception following poor ovarian response to gonadotrophin stimulation. Br J Obstet Gynaecol 1997; 104: 521–527
   PubMedGoogle Scholar
• Schoolcraft W, Schlenker T, Gee M, Stevens J, Wagley L. Improved controlled ovarian hyperstimulation in poor responder in vitro fertilization patients with a microdose follicle stimulating hormone flare, growth hormone protocol. Fertil Steril 1997; 67: 93–97
   PubMed Web of Science ®Google Scholar
• Lashen H, Ledger W, Barlow D. Poor responders to ovulation induction: is proceeding to in-vitro fertilization worthwhile?. Hum Reprod 1999; 14: 964–969
   PubMedGoogle Scholar
• Faber B, Mayer J, Cox B, Jones D, Toner J P, Oehninger S, Muasher S J. Cessation of gonadotropin-releasing hormone agonist and therapy combined with high dosage gonadotropin stimulation yields favourable pregnancy results in poor responders. Fertil Steril 1998; 69: 826–830
   PubMed Web of Science ®Google Scholar
• Rombauts L, Suikkari A, MacLachlan V, Trounson A O, Healy D L. Recruitment of follicle by recombinant follicle-stimulating hormone commencing in the luteal phase of ovarian cycle. Fertil Steril 1998; 69: 665–669
   PubMed Web of Science ®Google Scholar
• Pellicer A, Ballester M J, Serrano M D, Mir A, Serra-Serra V, Remohi J, Bonilla-Musoles F M. Aetiological factors involved in low response to gonadotrophins in infertile women with normal basal serum follicle stimulating hormone levels. Hum Reprod 1994; 9: 806–811
   PubMed Web of Science ®Google Scholar
• Cahill D J, Prosser C J, Wardle P G, Ford W C, Hull M G. Relative influence of serum follicle stimulating hormone, age and other factors on ovarian response to gonadotrophin stimulation. Br J Obstet Gynaecol 1994; 101: 999–1002
   PubMedGoogle Scholar
• Pellicer A, Ardiles G, Neuspiller F, Remohi J, Simon C, Bonilla-Musoles F. Evaluation of ovarian reserve in young low responders with normal basal levels of follicle-stimulating hormone using three-dimensional ultrasonography. Fertil Steril 1998; 70: 671–675
   PubMed Web of Science ®Google Scholar
• Collins J, Crosignani P G. Fertility and ageing. ESHRE Capri Workshop Group held in September 4–5, 2004. Hum Reprod Update 2005; 11: 261–275
   PubMedGoogle Scholar
• Templeton A, Morris J K, Parslow W. Factor that affect outcome of in-vitro fertilization treatment. Lancet 1996; 348: 1402–1406
   PubMed Web of Science ®Google Scholar
• Tarin J J. Aetiology of age-associated aneuploidy: a mechanism based on the free radical theory of ageing. Hum Reprod 1995; 10: 1563–1565
   PubMed Web of Science ®Google Scholar
• Munné S, Alikani M, Tomkin G, Grifo J, Cohen J. Embryo morphology, developmental rates, and maternal age are correlated with chromosome abnormalities. Fertil Steril 1995; 64: 382–391
   PubMed Web of Science ®Google Scholar
• Abdalla H, Thum M Y. An elevated basal FSH reflects a quantitative rather than qualitative decline of the ovarian reserve. Hum Reprod 2004; 19: 893–898
   PubMed Web of Science ®Google Scholar
• Bassil S, Godin P A, Donnez J. Outcome of in-vitro fertilization through natural cycles in poor responders. Hum Reprod 1999; 14: 1262–1265
   PubMed Web of Science ®Google Scholar
• Morgia F, Sbracia M, Schimberni M, Giallonardo A, Piscitelli C, Giannini P, Aragona C. A controlled trial of natural cycle versus microdose gonadotropin-releasing hormone analog flare cycles in poor responders undergoing in vitro fertilization. Fertil Steril 2004; 81: 1542–1547
   PubMed Web of Science ®Google Scholar
• Ubaldi F, Rienzi L, Ferrero S, Baroni E, Iacobelli M, Sapienza F, Minasi M G, Cobellis L, Romano S, Scarselli F, et al. Natural in vitro fertilization cycles. Ann N Y Acad Sci 2005; 1034: 245–251
   Google Scholar
• Land J, Yarmolinskaya M, Dumoulin J, Evers J L. High-dose human menopausal gonadotropin stimulation in poor responders does not improve in vitro fertilization outcome. Fertil Steril 1996; 65: 961–965
   PubMed Web of Science ®Google Scholar
• Akman M A, Erden H F, Tosun S B, Bayazit N, Aksoy E, Bahceci M. Addition of GnRH antagonist in cycles of poor responders undergoing IVF treatment. Hum Reprod 2000; 15: 2145–2147
   PubMedGoogle Scholar
• Akman M A, Erden H F, Tosun S B, Bayazit N, Aksoy E, Bahceci M. Comparison of agonistic flare-up protocol and antagonistic multiple dose protocol in ovarian stimulation of poor responders: results of a prospective randomized trial. Hum Reprod 2001; 16: 868–870
   PubMed Web of Science ®Google Scholar
• D'Amato G, Caroppo E, Pasquadibisceglie A, Carone D, Vitti A, Vizziello G M. A novel protocol of ovulation induction with delayed gonadotropin releasing hormone antagonist administration combined with high dose recombinant follicle stimulating hormone and clomiphene citrate for poor responders and women over 35 years. Fertil Steril 2004; 81: 1572–1577
   PubMed Web of Science ®Google Scholar
• Papaleo E, Fusi F M, De Santis L, Rabellotti E, Ferrari A. L'induzione dell'ovulazione nella paziente poor-responder: confronto fra differenti protocolli di stimolazione ovarica. Contraccezione, Fertilità e Sessualità 2002; 29: 161–164
   Google Scholar